The systemic lupus erythematosus (SLE) market continues to evolve toward biologic-driven care, with increasing treatment complexity, intensifying competition among advanced therapies, and a robust ...

First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers. A ...

Early and sustained adherence to antimalarials may help prevent RA and SLE disease flares, cardiovascular complications, and reduce future hospital use and costs.

Objectives Pulmonary diseases (PDs) in SLE are thought to be common and of clinical importance but can be difficult to ...

Patients with systemic lupus erythematosus (SLE) and atrial fibrillation (AF) exhibited elevated risks of severe cardiac complications, alongside increased in-hospital mortality, costs, and length of ...

CHICAGO — The current recommended benchmark for when to biopsy the kidney in patients with systemic lupus erythematosus (SLE) is arbitrary and results in missing the lupus nephritis (LN) cases that a ...

The implementation of a decision aid for systemic lupus erythematosus (SLE) in US clinics improved patient outcomes, including reduced decisional conflict and enhanced shared decision-making. Over 80% ...

Objectives Fatigue is one of the most common and debilitating symptoms experienced by patients with systemic lupus erythematosus (SLE). Previous studies revealed the association of fatigue with ...

Interpersonal relationships are crucial to healthy aging. Social isolation is associated with multiple adverse health outcomes in older adults, including depression. Those with chronic conditions, ...

SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other ...